Latest Supply Chain Management News

Brisbane Broncos Limited revealed solid financial results and operational growth for 2024 at their 2025 Annual General Meeting, highlighting record membership and commercial gains alongside strategic investments.

Austco Healthcare has renewed its preferred supplier agreement with a major US healthcare provider, continuing supply of its Tacera nurse call systems to 180 hospitals across 30 states. This extension builds on a lucrative five-year partnership worth over A$49 million.

Zimi Limited has paused its planned capital raising amid ongoing talks, while revealing strong operational momentum including $1.42 million in open orders and expanded market partnerships.

Reliance Worldwide Corporation outlines its strategic response to US tariffs, emphasizing diversified sourcing and price adjustments to sustain margins in a $25.3 billion plumbing market. The company forecasts broadly flat FY25 sales with slight margin pressure but remains confident in long-term growth.

Baby Bunting has reported a robust first half of FY25 with a 37% rise in pro forma NPAT and solid sales growth, underpinned by strategic execution and margin expansion.

Burgundy Diamond Mines has secured a novel diesel fuel offtake agreement with Macquarie Bank, easing seasonal cash flow pressures and potentially setting a precedent for multi-year collaboration.

Cleo Diagnostics reports steady progress in its U.S. and Australian clinical trials for an ovarian cancer blood test, maintaining a solid cash reserve of A$7.3 million as it prepares for FDA submission.

Nuchev Limited has reported its first positive operating cashflow quarter alongside a 65% increase in revenue for the first half of FY25, driven by strong sales growth and the bWellness acquisition.

Galan Lithium Limited has announced a substantial 150% increase in its Candelas Mineral Resource to 1.6 Mt LCE, lifting its total Hombre Muerto West resource to 9.5 Mt LCE and securing a spot among the world’s top 10 lithium projects.

Firebrick Pharma has made notable progress expanding its Nasodine nasal spray in Singapore, securing major distribution and marketing agreements that set the stage for retail sales growth in 2025.